Literature DB >> 25168081

Probability and predictors of the cannabis gateway effect: a national study.

Roberto Secades-Villa1, Olaya Garcia-Rodríguez2, Chelsea J Jin3, Shuai Wang3, Carlos Blanco3.   

Abstract

BACKGROUND: While several studies have shown a high association between cannabis use and use of other illicit drugs, the predictors of progression from cannabis to other illicit drugs remain largely unknown. This study aims to estimate the cumulative probability of progression to illicit drug use among individuals with lifetime history of cannabis use, and to identify predictors of progression from cannabis use to other illicit drugs use.
METHODS: Analyses were conducted on the sub-sample of participants in Wave 1 of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) who started cannabis use before using any other drug (n=6624). Estimated projections of the cumulative probability of progression from cannabis use to use of any other illegal drug use in the general population were obtained by the standard actuarial method. Univariate and multivariable survival analyses with time-varying covariates were implemented to identify predictors of progression to any drug use.
RESULTS: Lifetime cumulative probability estimates indicated that 44.7% of individuals with lifetime cannabis use progressed to other illicit drug use at some time in their lives. Several sociodemographic characteristics, internalizing and externalizing psychiatric disorders and indicators of substance use severity predicted progression from cannabis use to other illicit drugs use.
CONCLUSION: A large proportion of individuals who use cannabis go on to use other illegal drugs. The increased risk of progression from cannabis use to other illicit drugs use among individuals with mental disorders underscores the importance of considering the benefits and adverse effects of changes in cannabis regulations and of developing prevention and treatment strategies directed at curtailing cannabis use in these populations.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabis; Gateway; Other illicit drugs; Progression

Mesh:

Substances:

Year:  2014        PMID: 25168081      PMCID: PMC4291295          DOI: 10.1016/j.drugpo.2014.07.011

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  79 in total

1.  Is cannabis a stepping-stone for cocaine?

Authors:  Jan C van Ours
Journal:  J Health Econ       Date:  2003-07       Impact factor: 3.883

2.  Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Carlos Blanco; Donald Alderson; Elizabeth Ogburn; Bridget F Grant; Edward V Nunes; Mark L Hatzenbuehler; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2007-05-21       Impact factor: 4.492

Review 3.  Church and spirituality in the lives of the African American community.

Authors:  Joyce Newman Giger; Susan J Appel; Ruth Davidhizar; Claudia Davis
Journal:  J Transcult Nurs       Date:  2008-07-23       Impact factor: 1.959

4.  Cannabis use stages as predictors of subsequent initiation with other illicit drugs among French adolescents: use of a multi-state model.

Authors:  Aurélie Mayet; Stéphane Legleye; Bruno Falissard; Nearkasen Chau
Journal:  Addict Behav       Date:  2011-09-17       Impact factor: 3.913

5.  Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine.

Authors:  R I Desai; D J Barber; P Terry
Journal:  Behav Pharmacol       Date:  1999-11       Impact factor: 2.293

Review 6.  Possible contributors to the gender differences in alcohol use and problems.

Authors:  Susan Nolen-Hoeksema; Lori Hilt
Journal:  J Gen Psychol       Date:  2006-10

7.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

9.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

10.  Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.

Authors:  Sharaf S Khan; Roberto Secades-Villa; Mayumi Okuda; Shuai Wang; Gabriela Pérez-Fuentes; Bradley T Kerridge; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2012-11-22       Impact factor: 4.492

View more
  32 in total

1.  Assessing the longitudinal stability of latent classes of substance use among gay, bisexual, and other men who have sex with men.

Authors:  Kiffer G Card; Heather L Armstrong; Allison Carter; Zishan Cui; Lu Wang; Julia Zhu; Nathan J Lachowsky; David M Moore; Robert S Hogg; Eric A Roth
Journal:  Drug Alcohol Depend       Date:  2018-05-22       Impact factor: 4.492

2.  Marijuana Use in Youth from Bench to Bedside to Longitudinal Outlook.

Authors:  Elizabeth Osuch
Journal:  Can J Psychiatry       Date:  2016-06       Impact factor: 4.356

Review 3.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

4.  Physicians Warn Cannabis Can Cause Serious Health Hazards.

Authors:  Eric A Voth
Journal:  Mo Med       Date:  2021 May-Jun

Review 5.  Consequences of Perinatal Cannabis Exposure.

Authors:  Andrew F Scheyer; Miriam Melis; Viviana Trezza; Olivier J J Manzoni
Journal:  Trends Neurosci       Date:  2019-10-08       Impact factor: 13.837

Review 6.  Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Authors:  Yuichi Akasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2019-12-05       Impact factor: 3.872

Review 7.  The therapeutic potential of cannabinoids for movement disorders.

Authors:  Benzi Kluger; Piera Triolo; Wallace Jones; Joseph Jankovic
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

Review 8.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

9.  Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys.

Authors:  Deborah S Hasin; Melanie Wall; Katherine M Keyes; Magdalena Cerdá; John Schulenberg; Patrick M O'Malley; Sandro Galea; Rosalie Pacula; Tianshu Feng
Journal:  Lancet Psychiatry       Date:  2015-06-15       Impact factor: 27.083

10.  Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Deborah S Hasin; Bradley T Kerridge; Tulshi D Saha; Boji Huang; Roger Pickering; Sharon M Smith; Jeesun Jung; Haitao Zhang; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2016-03-04       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.